During performance analysis and validation, ETzD demonstrated better performance than conventional PSA, PSAD, or TzPSAD for prostate cancer detection among prostates with stromal enlargement and moderately elevated PSA. The gene discussed is KLK3; the disease is Familial prostate cancer.